MERTK and breast carcinoma: By using the syngeneic EO771 breast cancer bone metastasis model, we observed increased bone volume and reduced osteoclast numbers in bones of those animals in which MERTK was not expressed in the myeloid lineage (LysM-cre+Mertkflox/flox) [26].